A toxicologia das Novas Substâncias Psicoativas (NSP)
Kelly Francisco da Cunha
September 28, 2022 DOI: 10.47749/t/unicamp.2022.1257057 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cross-sectional |
|---|---|
| Sample size | 462 |
| Population | Attendees at parties and electronic music festivals in three Brazilian states |
| Key findings | MDMA was the most identified substance (88% of samples), but 39% of samples contained at least one NPS, with ketamine (75%) being the most prevalent NPS; only 5% of volunteers reported NPS consumption, and 80% of samples contained multiple substances. |
Abstract
New Psychoactive Substances (NPS) emergence of in the global illicit market has grown significantly since the 2000s.Despite the drop in the number of new identifications annually, they still cause severe cases of intoxication, many of them fatal.The present work developed and validated a method for the analysis of more than 100 NPS and conventional drugs of abuse in oral fluid (OF) samples and analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS).462 samples were collected at parties and electronic music festivals in 3 Brazilian states and analyzed using the developed methodology.3,4-methylenedioxymethamphetamine (MDMA, 88%) was still the most identified substance in the samples, but 39% of them contained some NPS.Ketamine (75%) was the most prevalent, followed by methylone (15%) and N-ethylpentylone (10%).Even so, only 5% of the volunteers had reported some NPS consumption.Ingestion of multiple substances was very prevalent, with 80% of samples containing two or more substances.This was the first data published in Brazil containing epidemiological data on NPS consumption through the analysis of biological samples in a recreational context.Samples containing synthetic cathinones were quantified using microextraction by packed sorbent (MEPS), with limit of detection (LOD) of 0.05 ng/mL.Among the 41 samples, methylone, N-ethylpentylone, euthylone, mephedrone and 4-CEC were quantified.Samples containing LSD were quantified, as well as its main biotransformation product, 2-oxo-3-hydroxy-LSD, with LOD of 0.1 ng/mL.This was the first published data quantifying both analytes in authentic oral fluid samples.Also, to meet the need for more information regarding NPS, an in vitro metabolism assay of the synthetic cannabinoid ADB-4en-PINACA was performed using human liver microsomes (HLM) and analyzed with a high-resolution mass spectrometer.Of the 11 metabolites identified in vitro, 7 were confirmed in post mortem blood and urine samples, with the metabolites derived from hydroxylation and hydroxylation followed by internal hydrolysis being the most intense.
Citations in the library
Cites 10
- The Role of Metabolism in 3,4-(±)-Methylenedioxyamphetamine and 3,4-(±)-Methylenedioxymethamphetamine (Ecstasy) toxicity Therapeutic Drug Monitoring March 19, 2004
- Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans The International Journal of Neuropsychopharmacology June 24, 2015
- NBOMes–Highly Potent and Toxic Alternatives of LSD Frontiers in Neuroscience February 26, 2020
- “My Friend Said it was Good LSD”: A Suicide Attempt Following Analytically Confirmed 25I-NBOMe Ingestion Journal of Psychoactive Drugs October 20, 2014
- Metabolism of lysergic acid diethylamide (LSD): an update Drug Metabolism Reviews July 3, 2019
and 5 more in the library